Q BioMed Inc. (QBIO) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Q BioMed Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-0.20
Earnings Deficit
P/B Ratio
-0.16
Equity Deficit
Earnings Yield
-2.87%
Yield Gap
Profitability Health
Return on Equity
-
No data
Operating Margin
-
No data
Net Profit Margin
-
No data
Growth Indicators
Revenue Growth
-
No data
Net Income Growth
-
No data
EPS Growth
-
No data
Efficiency & Liquidity
Current Ratio
-
No data
Quick Ratio
-
No data
Asset Turnover
-
No data
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
2.71%
Weak
WeakModerateStrong
EV / Free Cash Flow
2.46x
Strong
WeakModerateStrong
Net Debt / EBITDA
-6.57x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
-
No data
Return on Invested Capital
6.79%
Weak
WeakModerateStrong
Cash Conversion Cycle
-
No data
Fortress screener guardrails
1/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for QBIO.
View Financial Statements